Designers: DCA Design International Ltd, Warwick, United Kingdom
Manufacturer: Sanofi Aventis Deutschland GmbH, Frankfurt am Main, Germany
AllStar® Connect is a new reusable insulin pen injector that connects by Bluetooth to a smartphone. It is intended to help people better manage diabetes by automatically and seamlessly keeping track of insulin usage.
Diabetes is a chronic condition in which the body does not produce or properly use insulin, potentially leading to severe health implications.
To help prevent these problems many people rely on insulin therapy, which can require administration of multiple doses of different insulins every day.
Frequent adjustments to insulin dosage are commonly needed to accommodate variations in diet or lifestyle.
Keeping track of this can be challenging and people are often overwhelmed by the complexities of managing life with diabetes.
AllStar® Connect helps by automatically recording the details of every insulin dose delivered. Dose records are transferred by Bluetooth to the patient’s smartphone, where they can be logged and reviewed.
These error-free records can help patients and their clinicians to assess how well they are managing diabetes and to make better healthcare decisions.
AllStar® Connect builds on the successful AllStar® pen injector, which was launched in 2012 and is now used around the world.
AllStar® Connect retains the format and operating steps of AllStar®, making it familiar and re-assuring for patients. It automatically synchronizes the size and timing of each injection to the patient’s smartphone with no additional steps.
Even if the pen is not within range of the smartphone, the data is not lost. Every dose delivered from AllStar® Connect is permanently stored within its memory and automatically downloaded the next time it is used with the phone.
The elegant design of AllStar® Connect is testament to a determination to create a connected pen injector with no compromises for the user.
Not only does it function conventionally, but the electronic features have been miniaturized so that the size and form factor are just like a regular pen too.
AllStar® Connect has been carefully engineered and rigorously tested to ensure reliable performance over its lifetime.
It needs no recharging or battery replacement and is designed to provide a troublefree life of approximately three years for an average patient.
Packaged in a sleek and discreet visual design, AllStar® Connect demonstrates that great things come in small packages.
AllStar® is a registered trademark of Sanofi.
